Sigma Investment Counselors Inc. Purchases 4,871 Shares of Oak Street Health, Inc. (NYSE:OSH)

Sigma Investment Counselors Inc. lifted its stake in shares of Oak Street Health, Inc. (NYSE:OSHGet Rating) by 14.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 38,442 shares of the company’s stock after purchasing an additional 4,871 shares during the quarter. Sigma Investment Counselors Inc.’s holdings in Oak Street Health were worth $632,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Renaissance Capital LLC grew its holdings in shares of Oak Street Health by 61.5% during the 2nd quarter. Renaissance Capital LLC now owns 52,520 shares of the company’s stock valued at $863,000 after purchasing an additional 19,990 shares during the last quarter. Amalgamated Bank boosted its position in Oak Street Health by 27.1% during the first quarter. Amalgamated Bank now owns 11,248 shares of the company’s stock valued at $302,000 after acquiring an additional 2,400 shares during the last quarter. The Manufacturers Life Insurance Company bought a new stake in Oak Street Health during the first quarter valued at $950,000. Capital Research Global Investors boosted its position in Oak Street Health by 61.0% during the first quarter. Capital Research Global Investors now owns 11,852,080 shares of the company’s stock valued at $318,584,000 after acquiring an additional 4,491,941 shares during the last quarter. Finally, Capital Group Private Client Services Inc. boosted its position in shares of Oak Street Health by 18.2% during the 1st quarter. Capital Group Private Client Services Inc. now owns 225,108 shares of the company’s stock worth $6,051,000 after purchasing an additional 34,739 shares in the last quarter. 91.33% of the stock is owned by institutional investors.

Insider Activity

In other news, CEO Michael T. Pykosz sold 157,534 shares of the stock in a transaction dated Tuesday, August 2nd. The stock was sold at an average price of $30.03, for a total transaction of $4,730,746.02. Following the transaction, the chief executive officer now directly owns 7,189,050 shares in the company, valued at approximately $215,887,171.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO Michael T. Pykosz sold 157,534 shares of the stock in a transaction dated Tuesday, August 2nd. The stock was sold at an average price of $30.03, for a total transaction of $4,730,746.02. Following the transaction, the chief executive officer now directly owns 7,189,050 shares in the company, valued at approximately $215,887,171.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Geoffrey M. Price sold 96,568 shares of the stock in a transaction dated Tuesday, June 28th. The shares were sold at an average price of $18.56, for a total value of $1,792,302.08. Following the transaction, the insider now owns 1,796,702 shares in the company, valued at $33,346,789.12. The disclosure for this sale can be found here. In the last three months, insiders have sold 9,087,019 shares of company stock worth $227,581,646. 11.40% of the stock is currently owned by insiders.

Oak Street Health Price Performance

Shares of NYSE:OSH traded down $1.74 on Friday, hitting $24.48. The company’s stock had a trading volume of 70,193 shares, compared to its average volume of 1,625,684. The company has a 50-day simple moving average of $27.35 and a 200 day simple moving average of $22.97. Oak Street Health, Inc. has a 1 year low of $13.29 and a 1 year high of $51.36. The company has a market capitalization of $5.91 billion, a PE ratio of -10.88 and a beta of 3.01. The company has a debt-to-equity ratio of 16.10, a current ratio of 1.57 and a quick ratio of 1.57.

Oak Street Health (NYSE:OSHGet Rating) last released its quarterly earnings results on Tuesday, August 2nd. The company reported ($0.66) earnings per share for the quarter, missing the consensus estimate of ($0.49) by ($0.17). Oak Street Health had a negative net margin of 27.11% and a negative return on equity of 1,883.59%. The business had revenue of $523.70 million during the quarter, compared to analysts’ expectations of $520.62 million. Sell-side analysts forecast that Oak Street Health, Inc. will post -2.44 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently issued reports on OSH. Stifel Nicolaus increased their price objective on shares of Oak Street Health from $25.00 to $35.00 in a research report on Wednesday, July 27th. Sanford C. Bernstein started coverage on shares of Oak Street Health in a research report on Thursday, May 26th. They set an “outperform” rating and a $26.00 price objective on the stock. Morgan Stanley raised their price target on shares of Oak Street Health from $19.00 to $30.00 and gave the company an “equal weight” rating in a research report on Wednesday, August 31st. UBS Group raised their price target on shares of Oak Street Health from $26.00 to $28.00 and gave the company a “neutral” rating in a research report on Wednesday, August 3rd. Finally, Cowen raised their price target on shares of Oak Street Health to $34.00 in a research report on Tuesday, August 9th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, Oak Street Health presently has an average rating of “Hold” and an average target price of $32.75.

About Oak Street Health

(Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.

Featured Articles

Want to see what other hedge funds are holding OSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oak Street Health, Inc. (NYSE:OSHGet Rating).

Institutional Ownership by Quarter for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.